z-logo
open-access-imgOpen Access
Cutting Edge: Class I Presentation of Host Peptides Following HIV Infection
Author(s) -
Heather D. Hickman,
Angela D. Luis,
Wilfried Bardet,
Rico Buchli,
Casey L. Battson,
Michael H. Shearer,
Kenneth W. Jackson,
Ronald C. Kennedy,
William H. Hildebrand
Publication year - 2003
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.171.1.22
Subject(s) - biology , mhc class i , intracellular , antigen presentation , peptide , cytotoxic t cell , major histocompatibility complex , intracellular parasite , human leukocyte antigen , antigen processing , human immunodeficiency virus (hiv) , virology , t cell , microbiology and biotechnology , immune system , antigen , immunology , biochemistry , in vitro
Class I MHC molecules bind intracellular peptides for presentation to cytotoxic T lymphocytes. Identification of peptides presented by class I molecules during infection is therefore a priority for detecting and targeting intracellular pathogens. To understand which host-encoded peptides distinguish HIV-infected cells, we have developed a mass spectrometric approach to characterize HLA-B*0702 peptides unique to or up-regulated on infected T cells. In this study, we identify 15 host proteins that are differentially presented on infected human T cells. Peptides with increased expression on HIV-infected cells were derived from multiple categories of cellular proteins including RNA binding proteins and cell cycle regulatory proteins. Therefore, comprehensive analysis of the B*0702 peptide repertoire demonstrates that marked differences in host protein presentation occur after HIV infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom